EWTX logo

Edgewise Therapeutics (EWTX) Working capital

annual working capital:

$451.62M+$141.40M(+45.58%)
December 31, 2024

Summary

  • As of today (July 6, 2025), EWTX annual working capital is $451.62 million, with the most recent change of +$141.40 million (+45.58%) on December 31, 2024.
  • During the last 3 years, EWTX annual working capital has risen by +$178.37 million (+65.28%).
  • EWTX annual working capital is now at all-time high.

Performance

EWTX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

quarterly working capital:

$422.06M-$29.56M(-6.55%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX quarterly working capital is $422.06 million, with the most recent change of -$29.56 million (-6.55%) on March 31, 2025.
  • Over the past year, EWTX quarterly working capital has dropped by -$104.76 million (-19.89%).
  • EWTX quarterly working capital is now -19.89% below its all-time high of $526.83 million, reached on March 31, 2024.

Performance

EWTX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

EWTX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+45.6%-19.9%
3 y3 years+65.3%+63.2%
5 y5 years+1871.2%-

EWTX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+65.3%-19.9%+72.9%
5 y5-yearat high+1871.2%-19.9%+236.8%
alltimeall timeat high+1871.2%-19.9%+236.8%

EWTX Working capital History

DateAnnualQuarterly
Mar 2025
-
$422.06M(-6.5%)
Dec 2024
$451.62M(+45.6%)
$451.62M(-6.0%)
Sep 2024
-
$480.48M(-4.3%)
Jun 2024
-
$502.26M(-4.7%)
Mar 2024
-
$526.83M(+69.8%)
Dec 2023
$310.23M(-8.9%)
$310.23M(+10.2%)
Sep 2023
-
$281.58M(-6.9%)
Jun 2023
-
$302.60M(-5.6%)
Mar 2023
-
$320.65M(-5.8%)
DateAnnualQuarterly
Dec 2022
$340.41M(+24.6%)
$340.41M(-4.6%)
Sep 2022
-
$356.84M(+46.2%)
Jun 2022
-
$244.13M(-5.6%)
Mar 2022
-
$258.61M(-5.4%)
Dec 2021
$273.25M(+118.1%)
$273.25M(-3.9%)
Sep 2021
-
$284.49M(-4.0%)
Jun 2021
-
$296.23M(-3.1%)
Mar 2021
-
$305.69M(+144.0%)
Dec 2020
$125.30M(+446.9%)
$125.30M
Dec 2019
$22.91M
-

FAQ

  • What is Edgewise Therapeutics annual working capital?
  • What is the all time high annual working capital for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual working capital year-on-year change?
  • What is Edgewise Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly working capital year-on-year change?

What is Edgewise Therapeutics annual working capital?

The current annual working capital of EWTX is $451.62M

What is the all time high annual working capital for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual working capital is $451.62M

What is Edgewise Therapeutics annual working capital year-on-year change?

Over the past year, EWTX annual working capital has changed by +$141.40M (+45.58%)

What is Edgewise Therapeutics quarterly working capital?

The current quarterly working capital of EWTX is $422.06M

What is the all time high quarterly working capital for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly working capital is $526.83M

What is Edgewise Therapeutics quarterly working capital year-on-year change?

Over the past year, EWTX quarterly working capital has changed by -$104.76M (-19.89%)
On this page